You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glofitamab

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

Not yet recruiting
  • Large B-cell Lymphoma
  • Glofitamab
  • +2 more
  • (no location specified)
Oct 3, 2023

Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Mantle Cell Lymphoma Refractory
  • Glofitamab
  • +3 more
  • (no location specified)
Apr 18, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Glofitamab
  • +4 more
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

Recruiting
  • Lymphoma
  • Beijing, China
  • +2 more
Oct 12, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • glofitamab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

    Not yet recruiting
    • Large B-Cell Lymphoma
    • Glofitamab
    • +5 more
    • Xi'an, China
      First Affiliated Hospital of Medical College of Xi'an Jiaotong U
    Sep 14, 2023

    DLBCL Trial (maplirpacept (PF-07901801), Glofitamab, Obinutuzumab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • maplirpacept (PF-07901801)
    • +2 more
    • (no location specified)
    May 30, 2023

    Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

    Not yet recruiting
    • Lymphoma
    • Lymphoma, Large B-Cell, Diffuse
    • Glofitamab
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Apr 4, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

    Not yet recruiting
    • Follicular Lymphoma
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 13, 2023

    Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)

    Recruiting
    • Relapsed/Refractory Diffuse Large B Cell Lymphoma
    • Glofitamab, Poseltinib, Lenalidomide
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 28, 2022

    Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

    Not yet recruiting
    • Mature B-Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 6, 2022

    Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Duarte, California
      City of Hope Medical Center
    Sep 20, 2023

    DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

    Recruiting
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Glofitamab
    • +6 more
    • Pembroke Pines, Florida
    • +3 more
    Jan 23, 2023

    Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell Lymphoma Trial in Duarte

    Not yet recruiting
    • Blastoid Variant Mantle Cell Lymphoma
    • +2 more
    • Biopsy
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    May 15, 2023

    Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • Glofitamab
    • +3 more
    • Linz, Austria
    • +17 more
    Mar 22, 2023

    Lymphoma Trial in China (Obinutuzumab, Glofitamab, Tocilizumab)

    Recruiting
    • Lymphoma
    • Beijing, China
    • +6 more
    Aug 4, 2022

    Lymphoma, Non-Hodgkin Trial in Worldwide (RO7443904, Glofitamab, Obinutuzumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • New York, New York
    • +7 more
    Jan 11, 2023

    Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)

    Recruiting
    • Large B-cell Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 21, 2022

    Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Pasadena, California
    • +14 more
    Jan 30, 2023

    Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

    Recruiting
    • Lymphoma
    • Glofitamab
    • +6 more
    • Duarte, California
    • +13 more
    Aug 18, 2022

    B-cell Lymphoma Trial in Randwick, Clayton, Fitzroy (Glofitamab, Gemcitabine, Oxaliplatin)

    Completed
    • B-cell Lymphoma
    • Glofitamab
    • +5 more
    • Randwick, New South Wales, Australia
    • +2 more
    Nov 23, 2021

    Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Glofitamab
    • +5 more
    • Charlotte, North Carolina
    • +21 more
    Jan 18, 2023

    B-Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Worldwide (Glofitamab, Obinutuzumab (G), Rituximab (R))

    Active, not recruiting
    • B-Cell Lymphoma
    • Non-Hodgkin Lymphoma
    • Glofitamab
    • +8 more
    • Birmingham, Alabama
    • +23 more
    Dec 2, 2022

    Diffuse Large B-cell Lymphoma Trial in Worldwide (Obinutuzumab, Glofitamab, Rituxumab)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • Birmingham, Alabama
    • +77 more
    Jul 25, 2022